- Home
- OUSTZ vs RVPHW Comparison
OUSTZ vs RVPHW Comparison
Compare OUSTZ & RVPHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OUSTZ
- RVPHW
- Stock Information
- Founded
- OUSTZ N/A
- RVPHW 2018
- Country
- OUSTZ United States
- RVPHW United States
- Employees
- OUSTZ 290
- RVPHW 14
- Industry
- OUSTZ Industrial Machinery/Components
- RVPHW Biotechnology: Pharmaceutical Preparations
- Sector
- OUSTZ Industrials
- RVPHW Health Care
- Exchange
- OUSTZ Nasdaq
- RVPHW Nasdaq
- Market Cap
- OUSTZ N/A
- RVPHW N/A
- IPO Year
- OUSTZ N/A
- RVPHW N/A
- Fundamental
- Price
- OUSTZ $0.13
- RVPHW $0.06
- Analyst Decision
- OUSTZ
- RVPHW
- Analyst Count
- OUSTZ 0
- RVPHW 0
- Target Price
- OUSTZ N/A
- RVPHW N/A
- AVG Volume (30 Days)
- OUSTZ N/A
- RVPHW 22.4K
- Earning Date
- OUSTZ N/A
- RVPHW 03-14-2025
- Dividend Yield
- OUSTZ N/A
- RVPHW N/A
- EPS Growth
- OUSTZ N/A
- RVPHW N/A
- EPS
- OUSTZ N/A
- RVPHW N/A
- Revenue
- OUSTZ N/A
- RVPHW N/A
- Revenue This Year
- OUSTZ N/A
- RVPHW N/A
- Revenue Next Year
- OUSTZ N/A
- RVPHW N/A
- P/E Ratio
- OUSTZ N/A
- RVPHW N/A
- Revenue Growth
- OUSTZ N/A
- RVPHW N/A
- 52 Week Low
- OUSTZ N/A
- RVPHW $0.13
- 52 Week High
- OUSTZ N/A
- RVPHW $0.15
- Technical
- Relative Strength Index (RSI)
- OUSTZ N/A
- RVPHW N/A
- Support Level
- OUSTZ N/A
- RVPHW N/A
- Resistance Level
- OUSTZ N/A
- RVPHW N/A
- Average True Range (ATR)
- OUSTZ 0.00
- RVPHW 0.00
- MACD
- OUSTZ 0.00
- RVPHW 0.00
- Stochastic Oscillator
- OUSTZ 0.00
- RVPHW 0.00
About OUSTZ Ouster Inc. Warrants
Ouster Inc is a provider of lidar sensors for the automotive, industrial, robotics, and smart infrastructure industries. Ouster's products include high-resolution scanning and solid-state digital lidar sensors, Velodyne Lidar sensors, and software solutions. The company operates in the Americas, Asia and Pacific, Europe, Middle East, and Africa regions. It derives maximum revenue from Americas.
About RVPHW Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.